Home » Topics » Regulatory » Patents

Patents
RSS

Novel antiinfective agents disclosed in recent AstraZeneca and Novozymes patents

Jan. 10, 2007

Patents disclose therapeutic agents for schizophrenia, depression and other psychological disorders

Jan. 10, 2007

Novel therapeutic agents for gastrointestinal disorders claimed in recent patents

Jan. 9, 2007

New JAK3 inhibitors emerge from Rigel R&D

Jan. 9, 2007

Novel agents for treating neurological disorders disclosed in recent patents

Jan. 9, 2007

Recent patents reveal discovery of novel antidiabetic agents

Jan. 8, 2007

Novel agents for cardiovascular disorders claimed

Jan. 8, 2007

New analgesic agents described in recent patents

Jan. 8, 2007

Recent patents report discovery of novel oncolytic drugs

Jan. 5, 2007

Novel antiinflammatory agents described in recent patents

Jan. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...